CFG
Cooper Financial Group’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.58M | Sell |
8,489
-1,569
| -16% | -$291K | 0.19% | 95 |
|
|
2025
Q1 | $2.11M | Sell |
10,058
-183
| -2% | -$38.3K | 0.28% | 69 |
|
|
2024
Q4 | $1.82M | Buy |
10,241
+668
| +7% | +$119K | 0.22% | 86 |
|
|
2024
Q3 | $1.89M | Sell |
9,573
-2,792
| -23% | -$551K | 0.25% | 72 |
|
|
2024
Q2 | $2.12M | Sell |
12,365
-663
| -5% | -$114K | 0.31% | 62 |
|
|
2024
Q1 | $2.37M | Buy |
13,028
+1,587
| +14% | +$289K | 0.39% | 44 |
|
|
2023
Q4 | $1.77M | Buy |
11,441
+659
| +6% | +$102K | 0.32% | 58 |
|
|
2023
Q3 | $1.61M | Sell |
10,782
-326
| -3% | -$48.6K | 0.39% | 57 |
|
|
2023
Q2 | $1.5M | Buy |
11,108
+712
| +7% | +$95.9K | 0.37% | 62 |
|
|
2023
Q1 | $1.66M | Buy |
10,396
+722
| +7% | +$115K | 0.45% | 50 |
|
|
2022
Q4 | $1.56M | Buy |
9,674
+2,432
| +34% | +$393K | 0.48% | 46 |
|
|
2022
Q3 | $972K | Buy |
7,242
+691
| +11% | +$92.7K | 0.35% | 72 |
|
|
2022
Q2 | $1M | Buy |
6,551
+1,137
| +21% | +$174K | 0.36% | 70 |
|
|
2022
Q1 | $878K | Sell |
5,414
-297
| -5% | -$48.2K | 0.33% | 65 |
|
|
2021
Q4 | $773K | Sell |
5,711
-3,782
| -40% | -$512K | 0.29% | 87 |
|
|
2021
Q3 | $1.02M | Buy |
9,493
+1,122
| +13% | +$121K | 0.21% | 71 |
|
|
2021
Q2 | $943K | Buy |
8,371
+1,698
| +25% | +$191K | 0.19% | 79 |
|
|
2021
Q1 | $722K | Sell |
6,673
-4,558
| -41% | -$493K | 0.16% | 91 |
|
|
2020
Q4 | $1.2M | Buy |
11,231
+4,848
| +76% | +$519K | 0.25% | 70 |
|
|
2020
Q3 | $559K | Buy |
6,383
+839
| +15% | +$73.5K | 0.16% | 92 |
|
|
2020
Q2 | $544K | Buy |
5,544
+352
| +7% | +$34.5K | 0.18% | 81 |
|
|
2020
Q1 | $396K | Buy |
5,192
+1,126
| +28% | +$85.9K | 0.17% | 90 |
|
|
2019
Q4 | $360K | Buy |
4,066
+626
| +18% | +$55.4K | 0.14% | 91 |
|
|
2019
Q3 | $261K | Buy |
+3,440
| New | +$261K | 0.12% | 114 |
|